Effects of Autoantibodies Against AT1 Receptor from Patients with Refractory Hypertension on Intracellular Ca2+ Mobilization of Rat Vascular Smooth Muscle Cells

ZHU Feng,LIAO Yuhua,CHEN Ming,WEI Yumiao,WANG Ming

DOI: https://doi.org/10.3969/j.issn.1001-1439.2007.09.013

2007-01-01

Journal of Clinical Cardiology

Abstract:Objective:To explore the effect of autoantibodies against AT1 receptor of patients with refractory hypertension on the intracellular Ca2+ mobilization in vascular smooth muscle cells (VSMC).Method:Forty-six patients with hypertension were recruited and divided into two groups based on whether their blood pressure was above or below 140/90 mmHg after combination drug therapy: a refractory hypertension group (n=22) and a non-refractory hypertension group (n=24). The epitope of the second extracellular loop of AT1 receptor was synthesized and used as antigen to screen the antibodies by ELISA. IgG from patients with the refractory hypertension was obtained by affinity purification, and was used to prove the affinity with AT1-receptor in the cultured vascular smooth muscles (VSMC) by immunocytochemistry. Then, Fluo-3/AM, a Ca2+ fluorescent indicator was used to load VSMC. IgG from patients was used to stimulate VSMC and the change of fluorescence was monitored by confocal microscopy.Result:Frequency of the autoantibodies against AT1 receptor in refractory hypertension group was higher than that in non-refractory hypertension group (P0.05). And VSMC showed increased intracelluar Ca2+ mobilization induced by the patients’ antibodies against AT1 receptor. Furthermore, we found the autoantibody-induced Ca2+ increase could be blocked by losartan, an AT1 receptor antagonist.Conclusion: Antibodies against AT1 receptor with the ability to activate AT1 receptor may account for Ca2+ increase in VSMC. And the autoantibodies may involve in the pathogenesis of hypertension, especially in patients refractory to drug treatment.